Almost four years after it was approved in Europe to treat the incurable rare disease systemic amyloid light-chain (AL) amyloidosis, Johnson & Johnson’s Darzalex has been given the go-ahead for ...

The following is a summary of “Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival,” published in ...

Determination of serum free light chains has become indispensable in the diagnosis and follow-up of AL amyloidosis. Manipulation of amyloid deposition and degradation might become possible in the ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.

The patient may also experience an abnormally high or abnormally low blood pressure in nephrotic syndrome (DiSalvo et al., 2002; Khan & Falk, 2001). Amyloid protein can limit the ability of the ...

Art Still is one of the best defensive ends in University of Kentucky football history, becoming the No. 2 overall pick in ...

Tove Jensen-Munroe’s AL amyloidosis diagnosis “derailed” her life. The avid cyclist, walker, and swimmer was studying a ...